US Broker Ratings

HUTCHMED (China) Limited (HCM) Stock Analysis: Uncovering a Strong Buy Potential with 51.92% Upside

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based healthcare company specializing in drug manufacturing, has piqued investor interest with its promising pipeline of targeted therapeutics and immunotherapies. Operating in the..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a 32% Potential Upside in the Biotech Sector

Belite Bio, Inc (BLTE) is capturing investor attention with its promising position in the biotechnology sector, driven by its innovative approach to addressing unmet medical needs. Based in San Diego,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Potential 166.88% Upside in the Healthcare Sector

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the realm of Medicare Advantage plans. As the company continues to..

Envista Holdings Corporation (NVST) Stock Analysis: Unveiling a 29.57% Upside Potential in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is carving out its niche in the healthcare sector, particularly within the medical instruments and supplies industry. With a market cap of $3.76 billion, this..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a Potential Upside of 24.58% in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find ICU Medical, Inc. (NASDAQ: ICUI) an intriguing option. With a market capitalization of $3.88 billion, this company is a notable..

Perrigo Company plc (PRGO) Investor Outlook: Evaluating a Strong 8.21% Dividend Yield Amidst Market Challenges

Perrigo Company plc (PRGO), a longstanding player in the healthcare sector, offers a diverse array of over-the-counter health and wellness solutions across the globe. Operating from its Dublin headquarters, the..

Concentra Group Holdings (CON) Stock Analysis: Unlocking a 17.92% Upside in the Healthcare Sector

Concentra Group Holdings Parent, Inc. (NASDAQ: CON) is generating buzz among investors with its robust presence in the healthcare sector. As a prominent player in the medical care facilities industry,..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating Stability with a $10.22 Billion Market Cap

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a promising player in the biotechnology sector, focusing on innovative biologic therapies for immunological and inflammatory diseases. With a substantial market cap of $10.22..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exciting 92% Upside Potential Amid Strong Buy Ratings

Xenon Pharmaceuticals Inc. (XENE), a pioneering player in the biotechnology sector, is capturing the attention of investors with its robust pipeline and a remarkable projected upside. With a market capitalization..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Unveiling a Potential 55% Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a formidable contender in the biotechnology sector, capturing the attention of investors with its innovative approach to treating rare diseases. With a market..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Potential Upside Amidst Challenging Valuation Metrics

For investors seeking opportunities in the healthcare sector, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) presents an intriguing case. Known for its comprehensive range of dental equipment and healthcare consumables, the company..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a Potential 28% Upside with Robust Growth Prospects

Investors eyeing the biotechnology sector might want to turn their attention to ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company that stands at the forefront of neurological and rare disease..

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Shows a Potential 91% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering entity in the biotechnology sector, has captured the attention of investors with its promising portfolio aimed at treating rare and ultra-rare genetic diseases...

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Waters with a Forward P/E of 7.64

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading biotech firm, is making waves in the healthcare sector with its innovative RNA-targeted therapeutics and gene therapy solutions. As a major player in..

Oscar Health, Inc. (OSCR) Stock Analysis: Revenue Growth and Strategic Positioning Drive Investor Interest

Oscar Health, Inc. (NYSE: OSCR) is catching the eye of investors with its impressive revenue growth and strategic positioning in the healthcare plans sector. With a market cap of $9.92..

Cytokinetics, Incorporated (CYTK): Analyst Consensus Signals 59.78% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector, captivating investor attention with its promise in muscle activator and inhibitor therapies. Headquartered in South San Francisco, California, the company..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 175% Potential Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biopharmaceutical landscape, presents a compelling case for investors looking to capitalize on the burgeoning field of cell therapy. With its..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Option Care Health, Inc. (OPCH) Stock Analysis: Strong Buy Ratings and a 17.63% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector with its robust offerings in home and alternate site infusion services across the United States. With a market..

RadNet, Inc. (RDNT) Stock Analysis: 24.51% Potential Upside as Diagnostic Imaging Innovator

As the healthcare industry continues to evolve, RadNet, Inc. (NASDAQ: RDNT) stands out as a key player in the diagnostics and research sector. With a market capitalization of $5.98 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds